Market Place
Sourcing Support
Helsinki Court fines Orion Board member for securities offense
10 Apr 2025 //
PRESS RELEASE
Orion`s Interim Report for Jan-Mar 2025, Webcast on April 23
09 Apr 2025 //
PRESS RELEASE
Orion Corporation`s Annual Meeting Decisions on 3 April 2025
03 Apr 2025 //
PRESS RELEASE
Orion Corporation: Organising meeting of the Board of Directors
03 Apr 2025 //
PRESS RELEASE
Orion Makes Disclosure Under Chapter 9 Section 10 Securities
21 Mar 2025 //
GLOBENEWSWIRE
Orion Corp: Disclosure Under Chapter 9 Section 10 Securities Mark
20 Mar 2025 //
GLOBENEWSWIRE
Orion Corp: BlackRock Disclosure Under Securities Act
19 Mar 2025 //
GLOBENEWSWIRE
Orion Corp: Disclosure Under Chapter 9 Section 10 Securities Mark
17 Mar 2025 //
GLOBENEWSWIRE
Orion Corp: Disclosure Under Chapter 9 Section 10 Securities Mark
14 Mar 2025 //
GLOBENEWSWIRE
Orion Corp: Disclosure Under Chapter 9 Section 10 Securities Mark
13 Mar 2025 //
GLOBENEWSWIRE
Orion Corp: Disclosure Under Chapter 9 Section 10 Securities Mark
12 Mar 2025 //
GLOBENEWSWIRE
Orion Corporation: Managers’ transactions – Satu Ahomäki
11 Mar 2025 //
GLOBENEWSWIRE
Orion Corporation: Managers’ transactions – Hao Pan
11 Mar 2025 //
GLOBENEWSWIRE
Orion Corporation: Managers’ transactions – Juhani Kankaanpää
11 Mar 2025 //
GLOBENEWSWIRE
Orion Corporation: Managers’ transactions – Outi Vaarala
11 Mar 2025 //
GLOBENEWSWIRE
Orion Corporation: Managers transactions Ren© Lindell
11 Mar 2025 //
GLOBENEWSWIRE
Orion Corporation: Managers transactions Niclas Lindstedt
11 Mar 2025 //
GLOBENEWSWIRE
Orion Corporation: Managers™ transactions Julia Macharey
11 Mar 2025 //
GLOBENEWSWIRE
Orion Corporation: Managers™ transactions Olli Huotari
11 Mar 2025 //
GLOBENEWSWIRE
Orion Corporation: Managers™ transactions Liisa Hurme
11 Mar 2025 //
GLOBENEWSWIRE
Orion Group 2024 Financial Statement and Remuneration Report published
11 Mar 2025 //
GLOBENEWSWIRE
Orion To Open Biologics R&D Centre In Cambridge In 2025
10 Mar 2025 //
GLOBENEWSWIRE
Orion Corp: Disclosure Under Chapter 9 Section 10 Securities Mark
10 Mar 2025 //
GLOBENEWSWIRE
Orion Corporation: Transfer of 191,911 B shares on 10 March 2025
10 Mar 2025 //
GLOBENEWSWIRE
Orion and Aiforia extend collaboration to preclinical study evaluations
06 Mar 2025 //
PRESS RELASE
Orion Disclosure Under Securities Market Act (BlackRock, Inc.)
05 Mar 2025 //
GLOBENEWSWIRE
Orion Corp: Disclosure Under Chapter 9 Section 10 Securities Mark
05 Mar 2025 //
GLOBENEWSWIRE
Orion Disclosure Under Securities Market Act (BlackRock)
03 Mar 2025 //
GLOBENEWSWIRE
Orion Corporation: Manager™ transactions Niclas Lindstedt
28 Feb 2025 //
GLOBENEWSWIRE
Orion Corporation: Managers transactions Outi Vaarala
28 Feb 2025 //
GLOBENEWSWIRE
Orion Corporation: Managers’ transactions – Satu Ahomäki
27 Feb 2025 //
GLOBENEWSWIRE
Orion Corporation: Managers’ transactions – Hao Pan
27 Feb 2025 //
GLOBENEWSWIRE
Orion Group Financial Statement Release January–December 2024
25 Feb 2025 //
GLOBENEWSWIRE
Notice to the Annual General Meeting of Orion Corporation
25 Feb 2025 //
GLOBENEWSWIRE
Orion Approves Incentive Programs For Key Executives
25 Feb 2025 //
GLOBENEWSWIRE
Orion Corp.: Disclosure Under Chapter 9 Section 10 Securities Mar
19 Feb 2025 //
GLOBENEWSWIRE
Orion Corp: Disclosure Under Chapter 9 Section 10 Securities
18 Feb 2025 //
GLOBENEWSWIRE
Orion Reports BlackRock Disclosure Under Securities Market Act
17 Feb 2025 //
GLOBENEWSWIRE
Orion Discloses BlackRock Stake Under Securities Market Act
14 Feb 2025 //
PRESS RELEASE
Disclosure Under Chapter 9 Section 10 of the Securities Market Act
12 Feb 2025 //
PRESS RELEASE
Save the Date: Orion`s Capital Markets Day on 22 May 2025
10 Feb 2025 //
PRESS RELEASE
Invenra, Orion Partner For Bispecific Antibody Cancer Therapy
30 Jan 2025 //
PRESS RELEASE
Orion publishes Financial Statement Release for 2024
28 Jan 2025 //
PRESS RELEASE
Orion Committee Prepares Proposals For Annual Meeting Agenda
15 Jan 2025 //
PRESS RELEASE
Orion Announces Improved Financial Outlook For Coming Year
15 Jan 2025 //
PRESS RELEASE
79,345 Orion Corporation A shares converted into B shares
13 Jan 2025 //
PRESS RELEASE
Orion’s partner Bayer in China for 3rd indication of darolutamide
08 Jan 2025 //
PRESS RELEASE
Orion and Marinus terminate agreement for ganaxolone in Europe
02 Jan 2025 //
PRESS RELEASE
Orion and Marinus terminate agreement for ganaxolone in Europe
30 Dec 2024 //
#N/A
Change in Orion Group Executive Management Board
19 Dec 2024 //
GLOBENEWSWIRE
Orion Group Appoints Mikko as General Counsel Starting June 2025
19 Dec 2024 //
GLOBENEWSWIRE
Abilita and Orion Announce Research Collab to Next-Gen Antibody
19 Dec 2024 //
PRESS RELEASE
Orion Board Member Penalized for Delayed Transaction Notification
12 Dec 2024 //
GLOBENEWSWIRE
Orion Corporation Enters Collaboration with Evariste on Inhibitors
10 Dec 2024 //
BUSINESSWIRE
142,701 Orion Corporation A shares converted into B shares
27 Nov 2024 //
GLOBENEWSWIRE
Orion Research Foundation grants EUR 1,109,000 for research in 2025
22 Nov 2024 //
GLOBENEWSWIRE
Orion and Alligator Bio amend agreement 2 bispecific antibodies
20 Nov 2024 //
PRESS RELEASE
Orion & Alligator Bioscience Amend Bispecific Antibodies Agreement
19 Nov 2024 //
#N/A
Orion Corporation: Managers’ transactions – Henrik Stenqvist
01 Nov 2024 //
GLOBENEWSWIRE
Orion Group Interim Report January–September 2024
29 Oct 2024 //
GLOBENEWSWIRE
